T H E b E T H E s d a H a n d b o o k o F C L I n I C a L o n C o L o g y FourTH EdITIon 87588_fm_pi-xiv.indd 1 06/12/13 3:00 PM 87588_fm_pi-xiv.indd 2 06/12/13 3:00 PM T H E b E T H E s d a H a n d b o o k o F C L I n I C a L o n C o L o g y FourTH EdITIon eDitors Jame abraham, mD, FaCP Director, Breast Oncology Program Taussig Cancer Institute, Cleveland Clinic Cleveland, Ohio James L. GuLLey, mD, PhD, FaCP Chief, Medical Oncology Service Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda, Maryland Formerly of Emory University School of Medicine And Loma Linda University School of Medicine Carmen J. aLLeGra, mD Professor and Chief, Division of Hematology and Oncology Associate Director for Clinical and Translational Research Shands/University of Florida Cancer Center University of Florida Gainesville, Florida 87588_fm_pi-xiv.indd 3 06/12/13 3:00 PM Senior Executive Editor: Jonathan W. Pine Senior Product Manager: Emilie Moyer Director of Medicine Marketing: Lisa Zoks Manufacturing Manager: Beth Welsh Production Project Manager: Alicia Jackson Designer: Teresa Mallon Production Service: Integra Software Services Pvt. Ltd Printer: R.R. Donnelley Fourth Edition © 2014 by Lippincott Williams & Wilkins, a Wolters Kluwer business Two Commerce Square, 2001 Market Street Philadelphia, PA 19103 LWW.com 1st edition copyright 2000; 2nd edition copyright 2005; 3rd edition copyright 2010 by Lippincott Williams & Wilkins All rights reserved. This book is protected by copyright. No part of this book may be reproduced in any form or by any means, including photocopying, or utilized by any information storage and retrieval system without written permission from the copyright owner, except for brief quotations embodied in critical articles and reviews. Materials appearing in this book prepared by individuals as part of their official duties as U.S. govern- ment employees are not covered by the above-mentioned copyright. Printed in China Library of Congress Cataloging-in-Publication Data Bethesda handbook of clinical oncology / editors, Jame Abraham, James L. Gulley, Carmen J. Allegra. — Fourth edition. p. ; cm. Handbook of clinical oncology Includes bibliographical references and index. ISBN 978-1-4511-8758-8 I. Abraham, Jame, editor of compilation. II. Gulley, James L. (James Leonard), 1964- editor of compilation. III. Allegra, Carmen J., editor of compilation. IV. Title: Handbook of clinical oncology. [DNLM: 1. Neoplasms—therapy—Handbooks. QZ 39] RC262.5 616.99'4—dc23 2013039691 Care has been taken to confirm the accuracy of the information presented and to describe generally accepted practices. However, the authors, editors, and publisher are not responsible for errors or omissions or for any consequences from application of the information in this book and make no warranty, expressed or implied, with respect to the currency, completeness, or accuracy of the contents of the publication. Application of this information in a particular situation remains the professional responsibility of the practitioner. The authors, editors, and publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accordance with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of informa- tion relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly impor- tant when the recommended agent is a new or infrequently employed drug. Some drugs and medical devices presented in this publication have Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the healthcare provider to ascertain the FDA status of each drug or device planned for use in their clinical practice. 10 9 8 7 6 5 4 3 2 1 87588_fm_pi-xiv.indd 4 14/12/13 3:35 PM We dedicate this book to those lives that are touched by cancer and to their caregivers who spend endless hours taking care of them. “May I never forget that the patient is a fellow creature in pain. May I never consider him merely a vessel of disease.” —Maimonides (Twelfth-century philosopher and physician) n 87588_fm_pi-xiv.indd 5 06/12/13 3:00 PM c o n t r i b u t o r s Jame Abraham, MD, FACP Director, Breast Oscar S. Breathnach, MB, FRCPI Oncology Program Taussig Cancer Institute, Cleveland Consultant Medical Oncologist, Clinical Clinic Cleveland, Ohio Investigator, Beaumont Hospital, Connolly Hospital, Royal College of Surgeons, ICORG Bamidele A. Adesunloye, MD, MS Senior Clinical Fellow, Medical Oncology Service, National Dublin, Ireland Cancer Institute, National Institutes of Health, Christina Brzezniak, DO Clinical Fellow, Bethesda, Maryland Hematology and Oncology, Walter Reed National Sanjiv S. Agarwala, MD Professor of Medicine, Military Medical Center, Bethesda, Maryland Temple University; Chief, Oncology and Hematology, Mauricio E. Burotto Pichún, MD Senior St. Luke’s Cancer Center, Bethlehem, Pennsylvania Clinical Fellow, Medical Oncology Service, Sairah Ahmed, MD Assistant Professor of National Cancer Institute, National Institutes of Medicine, Division of Cancer Medicine, Department Health, Bethesda, Maryland of Stem Cell Transplantation and Cellular Therapy, Eric G. Bush, MD, MBA, RPh Medical The University of Texas M.D. Anderson Cancer Director, Frederick Memorial Hospital Pain and Center, Houston, Texas Palliative Care Service; Medical Director, Hospice Carmen J. Allegra, MD Professor and Chief, of Frederick County; Chairman, Ethics Committee, Division of Hematology and Oncology, Associate Frederick Memorial Hospital, Frederick, Maryland Director for Clinical and Translational Research, Jon Cardinal, MD Assistant Professor of Shands/University of Florida Cancer Center, Surgery, West Virginia University Hospital, University of Florida, Gainesville, Florida Morgantown,West Virginia Lukas C. Amler, PhD Director, Oncology George L. Carter, MMS, PA-C Physician Biomarker Development, Genentech, Inc., South San Assistant Medical Oncology Service, National Francisco, California Cancer Institute, National Institutes of Health, Christina M. Annunziata, MD, PhD Bethesda, Maryland Investigator, Medical Oncology Branch, National Ellie E. Chan, MD Assistant Professor of Cancer Institute, National Institutes of Health, Medicine, Division of Hematology and Oncology, Bethesda, Maryland University of California, San Francisco, Fresno Andrea B. Apolo, MD Assistant Clinical Medical Education, California Investigator, Head, Bladder Cancer Research Bruce D. Cheson, MD Professor of Medicine, Program, Medical Oncology Branch, Center for Head of Hematology; Deputy Chief, Division of Cancer Research, National Cancer Institute, National Hematology-Oncology, Georgetown University Institutes of Health, Bethesda, Maryland Hospital, Lombardi Comprehensive Cancer Center, Philip M. Arlen, MD Attending Physician, Washington, DC Medical Oncology Branch, Center for Cancer Richard W. Childs , MD Senior Investigator, Research, National Cancer Institute, National Hematology Branch, National Heart Blood and Institutes of Health, Bethesda, Maryland Lung Institute, National Institutes of Health, Anne Berger, MSN, MD Senior Clinician, Pain Bethesda, Maryland and Palliative Care Service, National Institute of Deborah Citrin, MD Investigator, Radiation Health Clinical Center, National Institutes of Health, Oncology Service, Center for Cancer Research, Bethesda, Maryland National Cancer Institute, National Institutes of Philippe C. Bishop, MD Vice President, Product Health, Bethesda, Maryland Development Oncology, Angiogenesis Franchise Head Barbara A. Conley, MD Associate Director, Genentech, Inc,. South San Francisco, California Cancer Diagnosis Program, Division of Cancer Christopher Bowden, MD Vice President, Treatment and Diagnosis, Department of Health Global Signing Franchise Head, Product Development, and Human Services, National Cancer Institute, Oncology, Genentech, South San Francisco, California National Institutes of Health, Rockville, Maryland vi 87588_fm_pi-xiv.indd 6 14/12/13 3:45 PM Contributors vii David P. Cosgrove, MB, BCh Assistant Professor, Juan C. Gea-Banacloche, MD Staff Clinician, Infectious Department of Medical Oncology, Sidney Kimmel Diseases, Experimental Transplantation and Immunology Comprehensive Cancer Center, Johns Hopkins University, Branch, National Cancer Institute, National Institutes of Baltimore, Maryland Health, Bethesda, Maryland Michael Craig, MD Associate Professor of Medicine, Thomas J. George, Jr., MD, FACP Associate Professor, Osborn Hematopoietic Malignancy and Transplantation Director, Gastrointestinal Oncology Program, Division of Program, West Virginia University, Morgantown, West Hematology and Oncology, University of Florida Health Virginia Cancer Center, Gainesville, Florida Aaron Cumpston, PharmD Pharmacy Clinical Giuseppe Giaccone, MD, PhD Chief, Medical Specialist, Osborn Hematopoietic Malignancy and Oncology Branch; Head, Thoracic Oncology Section, Transplantation Program, West Virginia University, National Cancer Institute, National Institutes of Health, Morgantown, West Virginia Bethesda, Maryland Brendan Curley, DO, MPH Fellow, Section of Govardhanan Nagaiah, MD Attending, Medical Hematology/Oncology, Mary Babb Randolph Cancer Center, Oncology/Hematology New Mexico Cancer Center, West Virginia University, Morgantown, West Virginia Albuquerque, New Mexico William L. Dahut, MD Clinical Director, Center for Ann W. Gramza, MD Medical Oncologist, Endocrine Cancer Research, National Cancer Institute, National Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Institutes of Health, Bethesda, Maryland Alexandre Buckley de Meritens, MD Senior Fellow Tim F. Greten, MD Chief, Gastrointestinal Cancer Molecular Signaling Section, Medical Oncology Branch, Section, Medical Oncology Branch, National Cancer Institute, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland National Institutes of Health, Bethesda, Maryland James L. Gulley, MD, PHD, FACP Chief, Medical Suzanne G. Demko, PA-C Clinical Team Leader, Oncology Service, Center for Cancer Research, Neuro-Oncology, Pediatric Oncology and Rare Tumors Group, National Cancer Institute, National Institutes of Health Division of Oncology Products 2, Office of Hematology and Bethesda, Maryland, Formerly of Emory University School of Oncology Products, Center for Drug Evaluation and Research, Medicine, And Loma Linda University School of Medicine U.S. Food and Drug Administration, Silver Spring, Maryland Karl E. Haglund, MD, PhD Assistant Clinical Marnie G. Dobbin, MS, RD Clinical Research Dietitian, Investigator, Radiation Oncology Branch, National Cancer Clinical Research Center, National Institutes of Health, Institute, National Institutes of Health, Bethesda, Maryland Bethesda, Maryland Mehdi Hamadani, MD Associate Professor of Medicine, Mark K. Doherty, MB BCh BAO Consultant, Division of Hematology & Oncology, Medical College of University College Hospital Galway, Galway, Ireland Wisconsin & CIBMTR, Milwaukee, Wisconsin Jennifer M. Duff, MD Fellow, Division of Hematology Chad A. Hamilton, MD, Lt Col, USAF, MC and Oncology, University of Florida Health Cancer Center, Chief, Gynecologic Oncology Service; Co-Director, DOD Gainesville, Florida Gynecologic Cancer Translational Research Center, Walter Reed National Military Medical Center, Bethesda, Maryland Austin Duffy, MB, MRCPI Staff Clinican, Gastrointestinal Malignancies Section, Medical Oncology Garrett M. Hampton, PhD Senior Director, Oncology Branch, National Cancer Institute, National Institutes of Biomarker Development, Genentech, Inc., South San Health, Bethesda, Maryland Francisco, California Kieron Dunleavy, MD Staff Clinican, National Cancer Hannah W. Hazard, MD, FACS Assistant Professor Institute, National Institutes of Health, Bethesda, Maryland of Surgery, Chief of Surgical Oncology, Assistant Dean for Daniel E. Elswick, MD Assistant Professor, Director, Admissions, West Virginia University School of Medicine, West Virginia Psychosocial Oncology Services, Department of Behavioral Medicine and Psychiatry, West Virginia University, Christopher Ryan Heery, MD Staff Clinician, Laboratory Morgantown, West Virginia of Tumor Immunology and Biology, National Cancer Institute, Sharon Romano Fitzgerald, MD Fellow, Gynecologic National Institutes of Health, Bethesda, Maryland Oncology, Walter Reed National Military Medical Center Upendra P. Hegde, MD Associate Professor of and Medical Oncology Branch, Center for Cancer Research, Medicine, Associate Director of Cutaneous Melanoma National Cancer Institute, National Institutes of Health, Program, University of Connecticut Health Center, Neag Bethesda, Maryland Comprehensive Cancer Center, Farmington, Connecticut Sheryl B. Fleisch, MD Psychosomatic Medicine Fellow, Lee J. Helman, MD Scientific Director for Clinical Department of Psychiatry, University of North Carolina, Research, Center for Cancer Research, National Cancer Chapel Hill, North Carolina Institute, National Institutes of Health, Bethesda, Maryland 87588_fm_pi-xiv.indd 7 06/12/13 3:00 PM viii cONTRIBUTORS Joleen M. Hubbard, MD Assistant Professor, Department Midhun Malla, MD, MBBS Internal Medicine, St. of Medical Oncology, Mayo Clinic, Rochester, Minnesota Joseph Hospital and Medical Center, Phoenix, Arizona Thomas E. Hughes, PharmD, BCOP Clinical Patrick J. Mansky, MD Medical Oncologist, Medical Pharmacy Specialist, Pharmacy Department, Clinical Research Director, Clinical Research, The Cancer Team at Bellin Center, National Institutes of Health, Bethesda, Maryland Health, Green Bay, Wisconson Geraldine Jacobson, MD, MPH, MBA, FACR Clifton Mo, MD Hematology/Oncology Staff Physician, Chair, Professor, Department of Radiation Oncology, West Department of Medicine, Walter Reed National Military Virginia University School of Medicine, WVU Healthcare, Medical Center, Bethesda, Maryland Morgantown, West Virginia Manish Monga, MD Assistant Professor of Medicine, Elaine S. Jaffe, MD Chief, Hematopathology Section Section of Hematology/Oncology; Medical Director, Clinical Laboratory of Pathology, Center for Cancer Research, Trial Research Unit, Mary Babb Randolph Cancer Center, National Cancer Institute, National Institutes of Health, West Virginia University Hospital, Morgantown, West Bethesda, Maryland Virginia Abraham S. Kanate, MD Assistant Professor of Dominic H. Moon, MD, MBBS National Institutes of Medicine, Section of Hematology/Oncology, Marry Babb Health, Medical Research Scholar Program Fellow, National Randolph Cancer Center, Morgantown, West Virginia Institutes of Health, Bethesda, Maryland Uzer Khan, MD Academic Chief Resident, Department Jarushka Naidoo, MB BCH BAO MRCPI Medical of Surgery, West Virginia University Hospitals, Morgantown, Oncology Specialist Registrar, Beaumont Hospital, Connolly West Virginia Hospital, Royal College of Surgeons, ICORG, Dublin, Ireland Hung T. Khong, MD Associate Professor, Division of Julie Nangia, MD Assistant Professor, Lester and Sue Smith Oncology, Huntsman Cancer Institute, University of Utah, Breast Center, Baylor College of Medicine, Houston, Texas Salt Lake City, Utah Anne M. Noonan, MB BCh BAO, MSc, MRCPI Joseph Woong Kim, MD Senior Clinical Fellow, Medical Investigator, Medical Oncology Branch, National Cancer Oncology Service, National Cancer Institute, National Institute, National Institutes of Health, Bethesda, Maryland Institutes of Health, Bethesda, Maryland Maryland Pao, MD Clinical Director, National Institute Stephen Ko, MD Instructor, Department of Radiation of Mental Health, National Institutes of Health, Bethesda, Oncology, Mayo Clinic Florida, Jacksonville, Florida Maryland David R. Kohler, PharmD Staff Scientist, Clinical Muzaffar H. Qazilbash, MD Professor of Medicine, Center Pharmacy Department, National Institutes of Health, Department of Stem Cell Transplantation and Cellular Bethesda, Maryland Therapy, Division of Cancer Medicine, The University of Elise C. Kohn, MD Head, Women’s Cancers Clinic; Head, Texas M.D. Anderson Cancer Center, Houston, Texas Molecular Signaling Section; Senior Investigator, Medical Sarah Read, MD, MHS Director, Therapeutics Research Oncology Branch, Center for Cancer Research, National Cancer Program, Division of AIDS, National Institute of Allergy and Institute, National Institutes of Health, Bethesda, Maryland Infections Diseases, National Institutes of Health, Bethesda, Teri Kreisl, MD Staff Clinician, Neuro-Oncology Branch, Maryland National Cancer Institute, National Institutes of Health, Mark Roschewski, MD Staff Clinician, Lymphoma Bethesda, Maryland Therapeutics Section, Metabolism Branch, Center for Cancer Shaji K. Kumar, MD Professor of Medicine, Consultant, Research, National Cancer Institute, National Institutes of Division of Hematology, Department of Internal Medicine, Health, Bethesda, Maryland Mayo Clinic, Rochester, Minnesota Donald L. Rosenstein, MD Professor, Departments of Jung-min Lee, MD Assistant Clinical Investigator, Psychiatry and Medicine; Director, Comprehensive Cancer Women’s Cancers Clinic, Medical Oncology Branch, Center Support Program, University of North Carolina at Chapel for Cancer Research, National Cancer Institute, National Hill, Chapel Hill, North Carolina Institutes of Health, Bethesda, Maryland Inger Lerra Rosner, MD Director, Urology Oncology; Gregory D. Leonard Consultant, University College Associate Director, Center for Prostate Disease Research; Hospital Galway, Galway, Ireland Assistant Professor of Surgery, USUHS, Walter Reed National Military Medical Center, Bethesda, Maryland W. Marston Linehan, MD Chief, Urologic Oncology Branch, Center for Cancer Research, National Cancer Kerry Ryan, MPH, MS, PA-C Physician Assistant, Institute, National Institutes of Health, Bethesda, Maryland Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Ravi A. Madan, MD Assistant Clinical Investigator, Laboratory of Tumor Immunology and Biology, Medical Yogen Saunthararajah, MD Staff, Hematologic Oncology Branch, National Cancer Institute, National Malignancies and Blood Disorders, Taussig Cancer Institute, Institutes of Health, Bethesda, Maryland Cleveland Clinic, Cleveland, Ohio 87588_fm_pi-xiv.indd 8 14/12/13 3:36 PM Contributors ix Nilay A. Shah, MD Fellow, Section of Hematology/ Quoc Truong, MD Clinical Assistant Professor of Oncology, Department of Medicine, West Virginia University Hematology/Oncology, Cancer Center of Kansas, University Hospital, Morgantown, West Virginia of Kansas Medical Center, Wichita, Kansas Nishith K. Singh, MD Clinical Fellow, Laboratory of Chaitra S. Ujjani, MD Assistant Professor of Medicine, Tumor Immunology and Biology, National Cancer Institute, Division of Hematology-Oncology, Lombardi Comprehensive National Institutes of Health, Bethesda, Maryland Cancer Center, Georgetown University Hospital, Washington, DC Preet Paul Singh, MBBS Fellow in Hematology/ Oncology, Mayo Clinic, Rochester, Minnesota Carter Van Waes, MD, PhD Chief, Head and Neck Surgery Branch; Clinical Director, National Institute on Ramaprasad Srinivasan, MD, PhD Head, Molecular Deafness and Other Communication Disorders; Senior Cancer Section, Urologic Oncology Branch, Center for Cancer Investigator, Radiation Oncology Branch, National Research, National Cancer Institute, National Institutes of Cancer Institute, National Institutes of Health, Bethesda, Health, Bethesda, Maryland Maryland Lindsay C. Stansfield, PharmD, BCPS Oncology Wyndham Wilson, MD, PhD Chief, Lymphoma Pharmacy Resident, Pharmacy Department, National Therapeutics Section, Metabolism Branch, Center for Cancer Institutes of Health Clinical Center, Bethesda, Maryland Research, National Cancer Institute, National Institutes of Michael P. Stany, MD Assistant Professor, Uniformed Health, Bethesda, Maryland Services University of the Health Sciences, Bethesda, Maryland Sarah Zentack, ScM, CGC Instructor, Lester and Sue Annie Su, MD Fellow, Hematology/Oncology, Baylor Smith Breast Center, Baylor College of Medicine, Houston, Texas College of Medicine, Houston, Texas Anish Thomas, MBBS, MD Senior Clinical Fellow, Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 87588_fm_pi-xiv.indd 9 06/12/13 3:00 PM